PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
10 juin 2024 09h05 HE
|
ResMed Inc.
ResMed-supported research presented at SLEEP2024 demonstrates the effectiveness and value of positive airway pressure (PAP) treatment for OSA.
Distributor Orders Nexstim NBS System 5 for European Hospital
10 juin 2024 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 10 June 2024 at 9 AM (EEST) Distributor Orders Nexstim NBS System 5 for European Hospital Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS...
New study identifies higher risk of depression and anxiety among young men, gay or bisexual, and racialized Canadian men
30 mai 2024 08h00 HE
|
Canadian Men's Health Foundation
National study from the Canadian Men’s Health Foundation released for Men’s Health Month in June.
Infrared Sauna Use in UCSF Clinical Trial Shows Promise in Combating Depression
20 mai 2024 07h45 HE
|
Clearlight® — Infrared Saunas and Wellness Solutions
Berkeley, California, May 20, 2024 (GLOBE NEWSWIRE) -- In conjunction with May as Mental Health Awareness Month, preliminary results from a University of California, San Francisco (UCSF) clinical...
NeuroSigma Announces Acceptance into 2024 Cohort of the KidsX Accelerator Program
09 mai 2024 09h00 HE
|
NeuroSigma, Inc.
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced its acceptance into the 2024 cohort of the KidsX Accelerator Program. KidsX is a global leader in pediatric digital...
Finnish Hospital Orders Nexstim NBS System 5
08 mai 2024 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 8 May 2024 at 9 AM (EEST) Finnish Hospital Orders Nexstim NBS System 5 Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from a...
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
03 mai 2024 07h00 HE
|
GH Research PLC
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1...
Pacific Clinics Announces 100 Job Openings in Bay Area
25 avr. 2024 16h42 HE
|
Pacific Clinics
Campbell, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Pacific Clinics, California’s leading provider of community-based mental health and substance use services, has more than 100 open job positions...
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
23 avr. 2024 08h15 HE
|
Silo Pharma, Inc.
Intranasal Delivery of SPC-15 shows rapid and effective drug exposure for PTSD Therapy SARASOTA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”),...
Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor
17 avr. 2024 08h00 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, April 17, 2024 (GLOBE NEWSWIRE) -- An astonishing 44% of Americans feel they have lost time in their lives due to poor mental health. That number jumps to nearly 80% for those...